Osaic Holdings
RCUS icon

Osaic Holdings’s Arcus Biosciences RCUS Stock Holding History

Osaic Holdings’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$23.9K Buy
1,107
+7
+0.6% +$151 ﹤0.01% 5739
2025
Q4 		$26.2K Sell
1,100
-10
-0.9% -$204 ﹤0.01% 5681
2025
Q3 		$15.1K Buy
1,110
+6
+0.5% +$62 ﹤0.01% 6116
2025
Q2 		$8.99K Sell
1,104
-16
-1% -$137 ﹤0.01% 6221
2025
Q1 		$8.79K Buy
1,120
+988
+748% +$11.5K ﹤0.01% 5854
2024
Q4 		$1.97K Sell
132
-14
-10% -$229 ﹤0.01% 6618
2024
Q3 		$2.23K Buy
146
+81
+125% +$1.28K ﹤0.01% 6562
2024
Q2 		$990 Sell
65
-485
-88% -$7.83K ﹤0.01% 6822
2024
Q1 		$10.4K Sell
550
-597
-52% -$10.3K ﹤0.01% 5721
2023
Q4 		$21.9K Buy
1,147
+369
+47% +$5.9K ﹤0.01% 5449
2023
Q3 		$14K Sell
778
-842
-52% -$16.9K ﹤0.01% 5743
2023
Q2 		$34.5K Buy
1,620
+550
+51% +$10.5K ﹤0.01% 5192
2023
Q1 		$18.6K Sell
1,070
-245
-19% -$4.68K ﹤0.01% 5607
2022
Q4 		$27K Buy
1,315
+315
+32% +$8.67K ﹤0.01% 5367
2022
Q3 		$26K Hold
1,000
– – ﹤0.01% 5389
2022
Q2 		$27K Hold
1,000
– – ﹤0.01% 5406
2022
Q1 		$971K Hold
1,000
– – ﹤0.01% 2607
2021
Q4 		$42K Sell
1,000
-255
-20% -$9.89K ﹤0.01% 5267
2021
Q3 		$44K Hold
1,255
– – ﹤0.01% 5206
2021
Q2 		$35K Hold
1,255
– – ﹤0.01% 5306
2021
Q1 		$37K Sell
1,255
-601
-32% -$20.9K ﹤0.01% 5089
2020
Q4 		$48K Buy
1,856
+1,016
+121% +$24.6K ﹤0.01% 4587
2020
Q3 		$14K Buy
840
+50
+6% +$1.12K ﹤0.01% 5114
2020
Q2 		$20K Hold
790
– – ﹤0.01% 4805
2020
Q1 		$11K Buy
+790
New +$9.82K ﹤0.01% 4956

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Osaic Holdings's RCUS Position: Q1 2026 in Review

Osaic Holdings increased its Arcus Biosciences (RCUS) stake by 0.64% in Q1 2026, buying an estimated $151 and bringing the position to 1,107 shares worth $23.9K. The position accounts for ﹤0.01% of the portfolio, ranked #5739.

Osaic Holdings first reported a position in RCUS in Q1 2020 and has held it in 25 quarters since. The position peaked at $971K in Q1 2022. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

  • Osaic Holdings held 1,107 shares of Arcus Biosciences worth $23.9K as of Q1 2026.
  • Osaic Holdings bought 7 Arcus Biosciences shares in Q1 2026, an estimated $151.
  • Arcus Biosciences made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #5739 holding.
  • Osaic Holdings first reported a position in Arcus Biosciences in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's Arcus Biosciences position peaked at $971K in Q1 2022.
  • 210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.